Log on / register
Feedback | Support | My details
Open AccessResearch article

Effect of buspirone on thermal sensory and pain thresholds in human volunteers

Goran Pavlaković email, Julija Tigges email and Thomas A Crozier email

Department of Anesthesiology, Emergency and Intensive Care Medicine, University of Göttingen Medical School, Göttingen, Germany

author email corresponding author email

BMC Clinical Pharmacology 2009, 9:12doi:10.1186/1472-6904-9-12

Published: 29 May 2009

Abstract

Background

Buspirone is a partial 5-HT1A receptor agonist. Animal studies have shown that modulation of serotoninergic transmission at the 5-HT1A receptor can induce analgesia in acute pain models. However, no studies have been published so far on the effects of serotonin receptor agonists on pain perception in humans.

Methods

The effects of buspirone (30 mg p.o.) on thermal sensory and pain thresholds were investigated in twelve female volunteers (26 ± 2 yrs) in a prospective, randomized, double-blind, double-dummy, placebo-controlled study with morphine (10 mg i.v.) as positive control.

Results

Morphine significantly increased the heat pain detection threshold (ΔT: placebo 1.0°C and 1.3°C, p < 0.05) at 60 minutes. Buspirone caused mild sedation in six participants at 60 minutes, but was without effect on any of the measured parameters.

Conclusion

Buspirone in the maximal recommended dose was without significant effect on thermal pain. However, as it is only a partial agonist at the 5-HT1A receptor and also acts on other receptor types, the negative results of the present study do not rule out a possible analgesic effect of more specific 5-HT1A receptor agonists.


© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.